Jennifer Angeline Gaddy

Dr. Jennifer Angeline Gaddy

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2018 in mBio
Verified
Journal Article
Open access
PDF file
RDRyan Doster
Ryan Doster
JSJessica A. Sutton
Jessica A. Sutton
LRLisa M. Rogers
Lisa M. Rogers
DADavid Aronoff
David Aronoff
Jennifer Angeline GaddyJennifer Angeline Gaddy
Jennifer Angeline Gaddy
Streptococcus agalactiae , also known as group B Streptococcus (GBS), is a common pathogen during pregnancy where infection can result in chorioamnionitis, preterm premature rupture of membranes (PPROM), preterm labor, stillbirth, and neonatal sepsis. Mechanisms by which GBS infection results in adverse pregnancy outcomes are still incompletely understood. This study evaluated interactions between GBS and placental macrophages. The data demonstrate that in response to infection, placental macrophages release extracellular traps capable of killing GBS. Additionally, this work establishes that proteins associated with extracellular trap fibers include several matrix metalloproteinases that have been associated with chorioamnionitis. In the context of pregnancy, placental macrophage responses to bacterial infection might have beneficial and adverse consequences, including protective effects against bacterial invasion, but they may also release important mediators of membrane breakdown that could contribute to membrane rupture or preterm labor.

3 February 2017 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
VKVishesh Kothary
Vishesh Kothary
RDRyan Doster
Ryan Doster
LRLisa M. Rogers
Lisa M. Rogers
LKLeslie A. Kirk
Leslie A. Kirk
KBKelli L. Boyd
Kelli L. Boyd
Jennifer Angeline GaddyJennifer Angeline Gaddy
Jennifer Angeline Gaddy
Streptococcus agalactiae, or Group B Streptococcus (GBS), is a gram-positive bacterial pathogen associated with infection during pregnancy and is a major cause of morbidity and mortality in neonates. Infection of the extraplacental membranes surrounding the developing fetus, a condition known as chorioamnionitis, is characterized histopathologically by profound infiltration of polymorphonuclear cells (PMNs, neutrophils) and greatly increases the risk for preterm labor, stillbirth or neonatal GBS infection. The advent of animal models of chorioamnionitis provides a powerful tool to study host-pathogen relationships in vivo and ex vivo. The purpose of this study was to evaluate the innate immune response elicited by GBS and evaluate how antimicrobial strategies elaborated by these innate immune cells affect bacteria. Our work using a mouse model of GBS ascending vaginal infection during pregnancy reveals that clinically isolated GBS has the capacity to invade reproductive tissues and elicit host immune responses including infiltration of PMNs within the choriodecidua and placenta during infection, mirroring the human condition. Upon interacting with GBS, murine neutrophils elaborate DNA-containing extracellular traps, which immobilize GBS and are studded with antimicrobial molecules including lactoferrin. Exposure of GBS to holo- or apo-forms of lactoferrin reveals that the iron-sequestration activity of lactoferrin represses GBS growth and viability in a dose-dependent manner. Together, these data indicate that the murine mouse model of ascending infection is a useful tool to recapitulate human models of GBS infection during pregnancy. Furthermore, this work reveals that neutrophil extracellular traps ensnare GBS and repress bacterial growth via deposition of antimicrobial molecules, which drive nutritional immunity via metal sequestration strategies.

1 July 2015 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
KHKathryn P Haley
Kathryn P Haley
ADAlberto G Delgado
Alberto G Delgado
MPM Blanca Piazuelo
M Blanca Piazuelo
BMBrittany L Mortensen
Brittany L Mortensen
PCPelayo Correa
Pelayo Correa
Jennifer Angeline GaddyJennifer Angeline Gaddy
Jennifer Angeline Gaddy
During infectious processes, antimicrobial proteins are produced by both epithelial cells and innate immune cells. Some of these antimicrobial molecules function by targeting transition metals and sequestering these metals in a process referred to as “nutritional immunity.” This chelation strategy ultimately starves invading pathogens, limiting their growth within the vertebrate host. Recent evidence suggests that these metal-binding antimicrobial molecules have the capacity to affect bacterial virulence, including toxin secretion systems. Our previous work showed that the S100A8/S100A9 heterodimer (calprotectin, or calgranulin A/B) binds zinc and represses the elaboration of the H. pylori cag type IV secretion system (T4SS). However, there are several other S100 proteins that are produced in response to infection. We hypothesized that the zinc-binding protein S100A12 (calgranulin C) is induced in response to H. pylori infection and also plays a role in controlling H. pylori growth and virulence. To test this, we analyzed gastric biopsy specimens from H. pylori -positive and -negative patients for S100A12 expression. These assays showed that S100A12 is induced in response to H. pylori infection and inhibits bacterial growth and viability in vitro by binding nutrient zinc. Furthermore, the data establish that the zinc-binding activity of the S100A12 protein represses the activity of the cag T4SS, as evidenced by the gastric cell “hummingbird” phenotype, interleukin 8 (IL-8) secretion, and CagA translocation assays. In addition, high-resolution field emission gun scanning electron microscopy (FEG-SEM) was used to demonstrate that S100A12 represses biogenesis of the cag T4SS. Together with our previous work, these data reveal that multiple S100 proteins can repress the elaboration of an oncogenic bacterial surface organelle.

1 September 2016 in Journal of Wound Care
Verified
Journal Article
Closed access
JHJennifer Hurlow
Jennifer Hurlow
EBE. Blanz
E. Blanz
Jennifer Angeline GaddyJennifer Angeline Gaddy
Jennifer Angeline Gaddy
Objective: The aim of this study was to analyse wound biofilm from a clinical perspective. Research has shown that biofilm is the preferred microbial phenotype in health and disease and is present in a majority of chronic wounds. Biofilm has been linked to chronic wound inflammation, impairment in granulation tissue and epithelial migration, yet there lacks the ability to confirm the clinical presence of biofilm. This study links the clinical setting with microscopic laboratory confirmation of the presence of biofilm in carefully selected wound debridement samples. Method: Human wound debridement samples were collected from adult patients with chronic non-healing wounds who presented at the wound care centre. Sample choice was guided by an algorithm that was developed based on what is known about the characteristics of wound biofilm. The samples were then evaluated by light microscopy and scanning electron microscopy for the presence of biofilm. Details about subject history and treatment were recorded. Adherence to biofilm-based wound care (BBWC) strategies was inconsistent. Other standard antimicrobial dressings were used and no modern antiseptic wound dressings with the addition of proven antibiofilm agents were available for use. Results: Of the patients recruited, 75% of the macroscopic samples contained biofilm despite the prior use of modern antiseptic wound dressings and in some cases, systemic antibiotics. Wounds found to contain biofilm were not all acutely infected but biofilm was present when infection was noted. The clinical histories associated with positive samples were consistent with ideas presented in the algorithm used to guide sample selection. Conclusion: Visual cues can be used by the clinician to guide suspicion of the presence of wound biofilm. This suspicion can be further enhanced with the use of a clinical algorithm. Standard antiseptic wound dressings used in this study demonstrated limited antibiofilm efficacy. This study also highlighted a need for the clinical team to focus on expiration of dressing action and consistent practice of BBWC strategies which includes the use of proven antibiofilm agents.

16 November 2021 in Infection and Immunity
Verified
Journal Article
Closed access
CWChristiaan D. M. Wijers
Christiaan D. M. Wijers
LPLy Pham
Ly Pham
SMSwapna Menon
Swapna Menon
KBKelli L. Boyd
Kelli L. Boyd
HNHannah R. Noel
Hannah R. Noel
MNMichael J. Noto
Michael J. Noto
Acinetobacter baumannii is a nosocomial pathogen that exhibits substantial genomic plasticity. Here, the identification of two variants of A. baumannii ATCC 17978 that differ based on the presence of a 44-kb accessory locus, named AbaAL44 ( A. baumannii accessory locus 44 kb), is described.

1 January 2016 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
KHKathryn P. Haley
Kathryn P. Haley
Jennifer Angeline GaddyJennifer Angeline Gaddy
Jennifer Angeline Gaddy
Helicobacter pyloricolonizes the stomachs of greater than 50% of the world’s human population making it arguably one of the most successful bacterial pathogens. ChronicH. pyloricolonization results in gastritis in nearly all patients; however in a subset of people, persistent infection withH. pyloriis associated with an increased risk for more severe disease outcomes including B-cell lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma) and invasive adenocarcinoma. Research aimed at elucidating determinants that mediate disease progression has revealed genetic differences in both humans andH. pyloriwhich increase the risk for developing gastric cancer. Furthermore, host diet and nutrition status have been shown to influenceH. pylori-associated disease outcomes. In this review we will discuss howH. pyloriis able to create a replicative niche within the hostile host environment by subverting and modifying the host-generated immune response as well as successfully competing for limited nutrients such as transition metals by deploying an arsenal of metal acquisition proteins and virulence factors. Lastly, we will discuss how micronutrient availability or alterations in the gastric microbiome may exacerbate negative disease outcomes associated withH. pyloricolonization.